L T Foods Q2 FY27 Earnings Call — Analysis (NSE: LTFOODS)
LT Foods delivered 17% YoY revenue growth in Q2FY27 to ₹3,253 Cr, maintaining double-digit top-line momentum while targeting medium-term consolidated EBITDA margins of 13.0%–13.5% as international and organic verticals achieve scale.
Result quality: stable — Steady quarter. Management sentiment: optimistic.
The take
Q2FY27 Consolidated Revenue ₹3,253 Cr ( +17% YoY ) , H1FY27 +22% . New guidance — H2 FY27 overall revenue and pat growth… Similar to H1 growth rates (~22% revenue / ~9% PAT) . New story: India Growth & Market Share Gains .
Results
Q2FY27 consolidated revenue rose 17% YoY to ₹3,253 Cr, EBITDA grew 13% YoY to ₹358 Cr (margin at 11.0%, -40bps YoY), and PAT increased 10% YoY to ₹180 Cr.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Consolidated Revenue | ₹3,253 Cr | +17% | yoy · Q2FY27 |
| Consolidated Gross Profit | ₹1,058 Cr | +12% | yoy · Q2FY27 |
| Consolidated EBITDA | ₹358 Cr | +13% | yoy · Q2FY27 |
| Consolidated EBITDA Margin | 11.00% | -40bps | yoy · Q2FY27 |
| Consolidated PAT | ₹180 Cr | +10% | yoy · Q2FY27 |
| H1FY27 Consolidated Revenue | ₹6,414 Cr | +22% | yoy · H1FY27 |
| H1FY27 Consolidated EBITDA | ₹721 Cr | +17% | yoy · H1FY27 |
| H1FY27 Consolidated PAT | ₹364 Cr | +9% | yoy · H1FY27 |
| Net Cash Position | ₹247 Cr | point_in_time · H1FY27 · Sep-26 | |
| ROCE | 22.40% | +40bps | yoy · H1FY27 |
Guidance
Management expects H2FY27 growth momentum to match H1FY27 and targets a 13.0%–13.5% consolidated EBITDA margin over the medium term, with the organic business targeting 10%–11% EBITDA margin in two years.
What management committed to
- We are confident on the margin target 13% to 13.5% to 14% of the EBITDA margin on consolidated basis. — 13% to 14%, not specified
- in the coming 2 years we are eyeing this business to also deliver 10 to 11% EBITDA margin. — 10% to 11%, FY29
- On a yearly basis, it will remain at 2.3%. — 2.3%, FY27
- In the coming quarters, as I said, as H1, H2 will also be very similar. So, we will be maintaining the momentum. — Similar to H1 growth rates (~22% revenue / ~9% PAT), H2 FY27
- In India, we are consolidating manufacturing through a new Madhya Pradesh facility with the first phase expected to commence operations in this financial year. — Phase 1 operational., FY27
- UK is definitely a part of our strategy as a Basmati company. UK is a big market. As far as when it will become profitable, as the scale will come which we expect in the next year we are looking it to be profitable. — Profitable, FY28
- I think by year end the things will be clear. — Clear, FY27
Key themes
Core Basmati expansion and international scale-up
How the narrative shifted
- India Growth & Market Share Gains: Positioning India as a strong growth engine with premiumization, portfolio expansion, and distribution deepening driving 140 bps market share gain and 8% branded portfolio growth against a nearly flat category.
- US Branded Foods Platform & Value-Added: Leveraging leadership in rice to build a broader branded foods platform in North America, supported by RTH facility investment and digital commerce capabilities to capture convenience-led occasions.
- European Business Restructuring: Acknowledging ongoing operating challenges and pressure on profitability, but emphasizing progress on customer base expansion, private label wins across Germany and Nordics, and a stronger underlying platform for future growth.
- Middle East Growth & Supply Disruption: Strong double-digit volume growth contrasted with severe profitability impact from supply disruptions and freight escalation; communicating active mitigation steps (alternate routing, pricing) with effects expected in future quarters.
- Organic Business Remodeling (Nature Bio Foods): Repositioning from an India-centric intermediary export model to a globally integrated consumer organic platform, accepting near-term revenue pressure for long-term value chain ownership and margin improvement.
- EBITDA Margin Trajectory and Investment Phase: Framing current consolidated 11% margin as a deliberate consequence of brand investments (2.5% of revenue), RTH buildout, and developing market scaling, with mature markets already delivering 15%+ and a medium-term target of 13-14%.
- Paddy Price Inflation and Pass-Through: Acknowledging a 22-25% YoY increase in crop prices but expressing strong confidence in the ability to pass costs through to consumers without demand destruction, citing the inelastic nature of specialty basmati demand and historical precedent.
- Freight and Logistics Cost Pressure: Highlighting a persistent 40 bps headwind to EBITDA from elevated shipping costs with partial pass-through in some markets and required absorption in others, notably Middle East and Europe.
- Working Capital Improvement & Capital Efficiency: Celebrating meaningful balance sheet progress: inventory days reduced sharply to 160 from 187, net cash position of INR 247 Cr, and ROCE improvement to 22.4%, disciplined capital allocation remains a priority.
Operational commentary
- Expanded mainstream private label relationships across Germany and Nordic markets while strengthening commercial coverage in France.
- Consolidating organic manufacturing under Nature Bio Foods through a new Madhya Pradesh facility, with Phase 1 slated for operationalization in FY27.
- India branded portfolio outpaced overall category growth (+8% vs 1.3%), gaining 140bps market share YTD, supported by Project Vistaar and expanding household reach to 67.5 lakh.
- Commissioning of expanded Ready-to-Heat (RTH) facility in the US is underway to support convenience food portfolio growth.
- Middle East business experienced freight escalation and shipping disruptions; management is implementing price hikes and alternate routing to recover margins in subsequent quarters.
Analyst Q&A
Q. Can management provide a specific timeline for reaching the 13.5% to 14% consolidated EBITDA margin target?
Management declined to give a specific calendar timeline as a matter of policy, emphasizing that mature markets already generate 15%+ EBITDA margins and overall margins will expand as investing markets scale up.
Q. What is the impact of higher crop/paddy procurement prices on future margins and pricing strategy?
Paddy prices are 22%-25% higher YoY, but raw material costs are roughly 70% of finished goods price; management noted that demand in specialty rice is relatively price-inelastic and cost increases will be passed on systematically.
Q. Why did the company discontinue disclosing absolute volume figures by geography?
Management stopped disclosing absolute volume breakdown across geographies for competitive reasons, but confirmed it will continue providing volume and value growth percentages.
Research and educational content only. Not investment advice.